Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.216 EUR | -1.82% | -.--% | -82.78% |
Apr. 29 | Mithra Pharmaceuticals to Postpone the Publication of Its Annual Report 2023 | CI |
Apr. 22 | Mithra Pharmaceuticals Obtains Court Protection Measures | MT |
Sales 2023 | 40.16M 43.21M | Sales 2024 * | 43.9M 47.24M | Capitalization | 14.93M 16.06M |
---|---|---|---|---|---|
Net income 2023 | -174M -187M | Net income 2024 * | -55M -59.18M | EV / Sales 2023 | 9.88 x |
Net Debt 2023 | 310M 334M | Net Debt 2024 * | 166M 179M | EV / Sales 2024 * | 4.13 x |
P/E ratio 2023 * |
-0.16
x | P/E ratio 2024 * |
-
| Employees | 270 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 81.67% |
1 day | -1.82% | ||
1 month | -12.20% | ||
3 months | -79.85% | ||
6 months | -85.21% | ||
Current year | -82.78% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 17-02-22 | |
Stijn Vlaminck
CTO | Chief Tech/Sci/R&D Officer | - | 21-04-30 |
Graham Dixon
CTO | Chief Tech/Sci/R&D Officer | 63 | 19-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jacques Galloy
BRD | Director/Board Member | 53 | 23-05-28 |
Christian Homsy
CHM | Chairman | 65 | 23-05-28 |
Valérie Gordenne
BRD | Director/Board Member | 51 | 21-05-19 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 0.216 | -.--% | 0 |
24-05-02 | 0.216 | -.--% | 0 |
24-04-30 | 0.216 | -.--% | 0 |
24-04-29 | 0.216 | -.--% | 0 |
24-04-26 | 0.216 | -1.82% | 82,336 |
Real-time Euronext Bruxelles, April 26, 2024 at 11:35 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-82.78% | 16.08M | |
-3.79% | 88.14B | |
+1.45% | 40.51B | |
-15.94% | 31.67B | |
+52.66% | 24.62B | |
-14.50% | 15.65B | |
-9.12% | 11.97B | |
-14.38% | 12.07B | |
-42.56% | 11.61B | |
+4.87% | 8.81B |
- Stock Market
- Equities
- MITRA Stock